Press Releases - Agena Bioscience

Agena Bioscience Launches New Pharmacogenetics (PGx) Panel Focused on Recommendations from Leading Societies More

Wednesday, November 13th, 2024

San Diego, CA – Agena Bioscience^®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the VeriDose Core Panel v2.0 for the detection of 85 variants across 16 pharmacogenetic...

Agena Bioscience and nRichDX Announce Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes More

Friday, April 14th, 2023

nRichDX Revolution Sample Prep System™ for cfDNA Extraction and Agena’s MassARRAY^® Platform for Detection of Rare Liquid Biopsy AnalytesSan Diego and Irvine, California – Agena Bioscience and nRichDX have advanced their existing...

Agena Bioscience & Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry More

Monday, November 29th, 2021

San Diego, CA – Agena Bioscience^® (part of Mesa Labs’ Clinical Genomics Division), a global provider of genetic testing solutions, today announced a partnership with Manchester University (MU) to expand awareness and access to...

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc. More

Tuesday, September 14th, 2021

Lakewood, Colorado – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has...

Agena Bioscience Signs Exclusive Distribution Agreement with AGBL Group of Companies More

Wednesday, March 10th, 2021

San Diego, CA – Agena Bioscience®, the global manufacturer of the MassARRAY® System for targeted genetic analysis, today announced an exclusive distribution agreement with Alliance Global, the AGBL Group of companies...

Agena Bioscience Launches New Panel for Detection and Discrimination of SARS-CoV-2 Variants of Concern More

Monday, March 1st, 2021

San Diego, CA – Agena Bioscience^®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the MassARRAY^® SARS-CoV-2 Variant Panel (RUO) for the detection of key SARS-CoV-2...

Agena Bioscience announces high-throughput, low-cost panel for molecular detection of SARS-CoV-2, Influenza A & Influenza B More

San Diego, CA – Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, today announced the launch of the MassARRAY^®

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel More

San Diego, CA – Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY^®

Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking More

San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it has obtained CE-IVD

Agena Bioscience Announces Release of High-Throughput, Low-Cost SARS-CoV-2 Panel More

San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the SARS-CoV-2

Agena Improves PGx Testing Accuracy with Launch of VeriDose™ CYP2D6 CNV Panel More

Quantification of Hybrid Alleles Not Detected by Common PGx TechnologiesSan Diego, CA, November 4, 2019– Agena Bioscience, a global provider of molecular

Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis More

San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID

Agena Bioscience® in the News

Recent Press Releases